On today's show, Hedley Rees explains exactly what failed gene therapy products for rare blood cancers launched in 2017 have to do with COVID and highlights some key points from his recent Substack article which breaks down how Bill Gates and the WHO "captured regulatory bodies across the globe."

GUEST OVERVIEW: Hedley Rees is a pharmaceutical supply chain management consultant with a strong background in the industry. He graduated from Cardiff University as a production engineer, holds a Diploma in Management Studies from the University of South Wales, and an Executive MBA from Cranfield University School of Management. Rees has extensive experience in senior supply chain management positions at various companies, including Bayer UK, British Biotech, Vernalis, Ortho-Clinical Diagnostics (previously J&J), and OSI Pharmaceuticals (now Astellas). In 2005, Hedley founded PharmaFlow, where he currently serves as Managing Consultant and Consultant in Strategic Supply-chain Management. He is also the author of the book “Supply Chain Management in the Drug Industry: Delivering Patient Value for Pharmaceuticals and Biologics” and has delivered numerous presentations on the topic at international conferences. You can follow him on X at: @hedleyrees and subscribe to his Substack at: hedleyrees.substack.com